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Progressive splenomegaly is a hallmark of visceral
leishmaniasis in humans, canids, and rodents. In ex-
perimental murine visceral leishmaniasis, spleno-
megaly is accompanied by pronounced changes in
microarchitecture, including expansion of the red
pulp vascular system, neovascularization of the white
pulp, and remodeling of the stromal cell populations
that define the B-cell and T-cell compartments. Here,
we show that Ly6C/G
 (Gr-1
) cells, including neu-
trophils and inflammatory monocytes, accumulate in
the splenic red pulp during infection. Cell depletion
using monoclonal antibody against either Ly6C/G

(Gr-1; RB6) or Ly6G
 (1A8) cells increased parasite
burden. In contrast, depletion of Ly6C/G
 cells, but
not Ly6G
 cells, halted the progressive remodeling of
Meca-32
 and CD31
 red pulp vasculature. Strikingly,
neither treatment affected white pulp neovasculariza-
tion or the remodeling of the fibroblastic reticular cell
and follicular dendritic cell networks. These findings
demonstrate a previously unrecognized compart-
ment-dependent selectivity to the process of splenic
vascular remodeling during experimental murine vis-
ceral leishmaniasis, attributable to Ly6C
 inflamma-
tory monocytes. (Am J Pathol 2011, 179:23–29; DOI:
10.1016/j.ajpath.2011.03.009)
Leishmaniasis, caused by protozoan parasites (genus
Leishmania), is a major neglected disease in resource-
poor countries. The species L. donovani and L. infantum
are responsible for visceral leishmaniasis, the most se-
vere form of the disease, which if untreated is almost
universally fatal.
1 In mouse models, as with human and
canine disease, the spleen is the site of chronic infec-
tion.
2 As infection progresses, marked splenomegaly de-
velops, associated with extensive remodeling of the lym-
phoid tissue microarchitecture. Elements of the marginal
zone are either lost or disrupted in their spatial organiza-
tion,
3 and follicular dendritic cells (FDCs) and fibroblastic
reticular cells (FRCs), the key stromal elements that un-
derpin B cell follicle integrity and form the T-cell zone
conduit system, respectively,
4,5 are progressively de-
nuded.
More recently, we and others have demonstrated that,
in murine experimental visceral leishmaniasis (EVL)
6 and
in canine VL,
7 there are pronounced changes to the
splenic vasculature that accompany splenomegaly. No-
tably, in EVL, Meca-32
 red pulp vessels are greatly
enlarged and show signs of angiogenesis. In the white
pulp, neovascularization leads to the appearance of nu-
merous CD31
SMA-1
 vessels that develop coincident
with a breakdown in the organization of the FRC and FDC
networks.
6 Studies in wild-type mice treated with neutral-
izing antibodies and in tumor necrosis factor (TNF)-defi-
cient mice have implicated the proinflammatory cytokine
tumor necrosis factor (which is overexpressed by mac-
rophages and many other cells during EVL) as a mediator
of white pulp stromal cell remodeling.
3,4 However, little is
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23known about the regulation of vascular remodeling within
the red pulp or neovascularization in the white pulp.
Both neutrophils and inflammatory monocytes have
recently attracted much interest in the study of leishman-
iasis, by acting as a host cells during infection
8-10 and by
playing a variety of regulatory roles that affect late stages
of both visceral and cutaneous disease.
10–12 More re-
cently, neutrophils that express matrix metalloproteinase
9 (MMP-9),
13–15 as well as inflammatory monocytes,
16
have been implicated in the regulation of angiogenesis in
a variety of experimental models of disease. In the con-
text of EVL, however, it is currently unknown whether
either cell population plays a role in the splenic tissue
remodeling that occurs during progressive disease.
In the present study, therefore, we sought to determine
the effects of depletion of these cells on the progressive
changes to splenic architecture that are characteristic of
this disease. With use of flow cytometry and confocal
microscopy, we show that Ly6C/G
high neutrophils and
Ly6C/G
int inflammatory monocytes are located within the
splenic red pulp and that their number increases during
infection. Depletion of either Ly6C/G
int/high cells [using
Gr-1 monoclonal antibody (mAb) RB6] or Ly6G
 cells
(using mAb 1A8) from day 21 to day 28 of infection
increased splenic parasite load, but these treatments
had distinctly different effects on splenic remodeling.
Gr-1 administration led to a selective arrest in red pulp
vascular remodeling, whereas neovascularization and
the disruption of stromal cell networks in the white pulp
continued unabated. In contrast, administration of mAb
1A8 had no effect on any aspect of splenic remodeling
that we measured. These data demonstrate for the first
time that the regulation of splenic vascular remodeling
during EVL occurs in a strictly compartmentalized man-
ner and is independent of mechanisms that control par-
asite burden.
Materials and Methods
Mice and Infection
Female C57BL/6 mice, 6 to 8 weeks old, were obtained
from Charles River UK (Margate, UK) and were housed
under specific-pathogen-free conditions. L. donovani
(LV9) amastigotes were obtained from the spleens of
infected Syrian hamsters, as described previously.
17
Mice were injected with 3  10
7 amastigotes i.v. via the
lateral tail vein. At day 21 and day 24 after infection,
mice were administered 0.2 mg i.p. of Ly6C/G-specific
Gr-1 (RB6-8C5) or 0.25 mg Ly6G-specific (1A8) mAbs
or their isotype control antibodies (AFRC Mac-5 or
Mac-4, respectively). Mice were sacrificed by cervical
dislocation at day 28 and spleens were removed for
analysis. All experiments were approved by the insti-
tutional ethics committee and were performed under
U.K. Home Office license.
IHC
Spleen sections (10-m thick) cut from spleens of both
uninfected and infected mice were fixed in ice-cold ac-
etone or 2% paraformaldehyde at room temperature for
15 minutes. Paraformaldehyde-fixed tissue sections were
then blocked and permeabilized by 0.1% bovine serum
albumin (w/w), 0.1% (v/v) saponin in PBS for 1 hour at
room temperature. For MMP-9 localization, sections were
double-stained with biotinylated rat anti-MMP-9 (R&D
Systems, Minneapolis, MN) and with allophycocyanin-
conjugated Gr-1, F4/80, or CD169 (eBioscience, San Di-
ego, CA) primary antibodies, followed by streptavidin
Alexa Fluor 488 or streptavidin Alexa Fluor 647. Slides
were washed three times with 0.1% (v/v) saponin in PBS.
The sections were dehydrated after staining, mounted
with antifade solution (Molecular Probes, Eugene, OR),
and visualized using a Zeiss Axioplan LSM 510 confocal
microscope. For the assessment of vascular changes,
sections were stained using biotinylated CD31 (eBiosci-
ence) or purified Meca-32 (BD Pharmingen, San Diego,
CA) followed by Alexa Fluor 488 streptavidin and fluores-
cein isothiocyanate goat anti-rat antibody (both from In-
vitrogen, Carlsbad, CA). Localization of Gr-1
 and F4/
80
 cells was performed using biotinylated mAb followed
by streptavidin conjugated to Alexa Fluor 546 and Alexa
Fluor 647 conjugated mAb, respectively. Data were an-
alyzed by quantitative morphometry, as described previ-
ously.
6
In Situ Zymography
In situ zymography with fluorescein isothiocyanate-la-
beled dye-quenched gelatin (Enz Chek; Molecular
Probes, Eugene, OR) was used to determine the local-
ization of MMP-9 activity in spleen sections. Unfixed
sections (8-m thick) were thawed, preincubated in
PBS at room temperature, and incubated with PBS
containing 40 g/mL dye-quenched gelatin (1 mg/mL)
in a humidified chamber overnight. At the end of the
incubation period, sections were washed three times
with PBS and then were dehydrated and mounted with
antifade solution. As controls, a general MMP inhibitor,
1,10-phenanthroline (10 mmol/L; Sigma-Aldrich, St.
Louis, MO), was added to the PBS/dye-quenched gel-
atin mixture and applied to frozen cryostat sections.
Nonspecific serine protease activity was blocked using
phenylmethylsulfonyl fluoride (Sigma-Aldrich). Images
were acquired with a Zeiss Axioplan LSM 510 confocal
microscope.
Flow Cytometry and Intracellular Enzyme
Detection
Splenic cells from naïve or infected mice were homog-
enized in RPMI and cells were counted on hemocytom-
eter. Then 1 to 2  10
6 cells per tube were resus-
pended in ice-cold PBS buffer consisting of 5 mmol/L
EDTA, 1% fetal calf serum, and 1% NaNO3. All stain-
ings were performed on ice. Splenic cells were surface
stained with phycoerythrin or allophycocyanin conju-
gated Gr-1, Ly6G-phycoerythrin, Ly6C-fluorescein iso-
thiocyanate, CD11b-Pacific blue, CD11c phycoeryth-
rin-Cy7, and MHCII-allophycocyanin. GR-1 stained
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NaNO3, resuspended in the same buffer, and incu-
bated 15 minutes on ice with 2% paraformaldehyde.
Fixed cells were then resuspended in PBS/EDTA/fetal
calf serum/NaNO3 containing 0.5% saponin and intra-
cellularly labeled with biotinylated anti-MMP-9. Biotin-
ylated antibodies were visualized with fluorescein iso-
thiocyanate-streptavidin. Background staining was
judged from appropriate isotype control mAbs. Flow
cytometric analysis was performed using a CyAn flow
cytometry system (Beckman Coulter, High Wycombe,
UK) and Summit 4.0 software.
Statistical Analysis
Statistical analysis was performed using a nonpaired Stu-
dent’s t-test and two-way analysis of variance. P  0.05
was considered significant. All experiments were re-
peated independently at least twice.
Results
CD11b
Ly6C
 Cells Accumulate in the Spleen
During L. donovani Infection
In the spleen of naïve mice, neutrophils can be distin-
guished from monocytes/DC using a combination of CD11b
and Ly6G (Figure 1A). Within the CD11b
Ly6G
 mono-
cyte/DC population, considerable heterogeneity was found
in expression of Ly6C, as has been observed by others.
18
During infection with L. donovani, the relative balance of
neutrophils to monocyte/DC shifts from a ratio of approxi-
mately 1:1 to approximately 1:6, reflecting recruitment of
inflammatory CD11b
Ly6G
 monocytes/DC cells that are
more homogeneous for Ly6C expression (Figure 1B). By
immunohistochemistry (IHC), two populations of Ly6C/G

cells were also readily distinguished (Figure 1, C and D),
both localized within the red pulp. Ly6C/G
bright cells, almost
invariably with polymorphonuclear appearance, were found
Figure 1. Identification of Ly6C/G
 cells in EVL. Spleens from L. donovani infected mice were removed at day 28 after infection and analyzed alongside spleens
from naïve mice by flow cytometry and by IHC. A and B: Spleen cells from naïve (A) and infected (B) mice were stained with Ly6G and CD11b and the expression
of Ly6C was determined on neutrophils (upper histograms) and monocytes/DC (lower histograms). C and D: Sections from naïve (C) and infected (D) mice were
stained for Ly6C/G (Gr-1; red) and F4/80 (green) and counterstained with DAPI (blue). Original magnification, 100. Insets show boxed areas at higher
magnification: Gr-1
bright neutrophils (C) and a nest of F4/80
Gr-1
dull cells with two neutrophils in close proximity (D). Original magnification, 630. E: Spleen
cells from infected mice treated with 1A8 or isotype control antibody were stained with Gr-1 and Ly6C. Gr-1
Ly6C
 neutrophils are highlighted in oval gated
regions. F: Spleen cells from infected mice treated with Gr-1 or isotype control antibody were stained with 1A8 and Ly6C. 1A8
Ly6C
 neutrophils are highlighted
in oval gated regions. G–J: Absolute numbers of splenic neutrophils (G and H) and monocytes/DC (I and J) in spleens of naïve mice and infected mice were
determined using Ly6G (1A8) and Ly6C for Gr-1-depleted mice (G and I) and using Ly6C and Gr-1 for 1A8-depleted mice (H and J). Data represent means  SEM
from 7 mice per group, pooled from two independent experiments for Gr-1 depletion and 4 mice per group from one experiment for 1A8 depletion. Similar results
were seen in an additional experiment in which 1A8-depleted mice were analyzed using CD11b and Ly6C (data not shown). **P  0.01, ***P  0.001. ns, not
significant. Peripheral blood neutrophils were depleted by 91  4% after 1A8 and 98  0.5% after Gr-1 depletion (data not shown). K: Spleen sections from
infected mice administered either isotype control (ISO) or 1A8 were stained for Gr-1 (red) and DAPI (blue). Original magnification, 200.
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most Ly6C/G
dull cells were concentrated in the subcapsular
red pulp and therefore likely represent the resident splenic
monocyte pool.
18 In contrast, in the spleens of infected
mice, large nests of Gr-1
dull cells could also readily be
observed throughout the red pulp (Figure 1D).
Previous reports have suggested monocytes, macro-
phages, and neutrophils as potent cellular sources of
proangiogenic MMP-9 during inflammation.
19 In the pres-
ent study, however, IHC analysis, in situ zymography, and
flow cytometry all revealed that in both naïve mice and
infected mice MMP-9 was colocalized almost exclusively
with Gr-1
bright cells, with minimal MMP-9 expression in
Gr-1
int monocytes/DC even after neutrophil depletion
(see Supplemental Figure S1 at http://ajp.amjpathol.org).
To determine the potential role of these two myeloid pop-
ulations in regulating vascular remodeling during infection,
we compared the effects of either depleting both popula-
tions (using Gr-1) or just Ly6G
 neutrophils (using 1A8).
Neutrophil depletion was similar in mice treated with either
mAb (Figure 1, E–H), whereas monocytes/DC were de-
pleted only after administration of Gr-1 (Figure 1, I and J).
Immunohistology of 1A8-treated mice showed an almost
complete absence of Gr-1
bright cells, a finding that, together
with the flow analysis, helped to confirm that most Gr-1
dull
cells detected by this method were monocytes/DC (Figure
1K). Consistent with previous studies,
11 administration of
Gr-1 mAb during established infection led to an increase in
splenic parasite burden: 195  17 versus 304  40 Leish-
man-Donovan units (LDU) at day 28 after infection in iso-
type-treated versus Gr-1-treated mice, respectively (n  10
mice; P  0.02). Similarly, administration of 1A8 also in-
creased parasite burden at day 28, from 53  12 LDU to
168  33 LDU (n  7 mice; P  0.001).
Ly6C
 Cells are Selectively Involved in Red Pulp
Vascular Remodeling
To assess the effects of monocyte and neutrophil deple-
tion on splenic vascular remodeling, we performed quan-
titative IHC on spleen sections from Gr-1 and 1A8 treated
Figure 2. Ly6C
 inflammatory monocytes/DC promote vascular remodeling in the red pulp. Spleens from mice infected with L. donovani were removed at day
28 after infection and analyzed alongside spleens from naïve mice by IHC. A and B: Spleen sections from naïve mice and infected mice treated with isotype control,
Gr-1, or 1A8 from day 21 to day 28 after infection were stained with Meca-32 (A) or with CD31 (B). Original magnification, 200. C–H: Computer-assisted
quantitative morphometry was performed to determine the expression of Meca-32 (C and D) and of CD31 (E and F) in the red pulp and also the expression of
CD31 in the white pulp (G and H) of mice treated with Gr-1 (C, E, and G) or 1A8 (D, F, and H). Data were generated from multiple sections examined from at
least 5 mice per group. *P  0.05, **P  0.01, and ***P  0.001.
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recognizes red and white pulp vasculature and the en-
dothelium of the marginal sinus in naïve mice.
6 As previ-
ously reported,
6 Meca-32
 vessels increased in abun-
dance in the red pulp of mice infected with L. donovani
(Figure 2A). Administration of Gr-1 mAb to mice from day
21 to day 28 after infection reduced the level of Meca-32
expression in red pulp to that seen in control uninfected
mice (Figure 2, A and C). In the red pulp, some large-
caliber vessels also stained for CD31 (data not shown),
and the increase in CD31 in the red pulp observed in
infected mice was also arrested after administration of
Gr-1 mAb (Figure 2E). Strikingly, when Ly6G
 cells alone
were depleted using 1A8, no effects were observed on
either of these two measures of splenic red pulp vascular
remodeling (Figure 2, A, D, and F). These findings indi-
cate that vascular remodeling in the red pulp is likely to
be dependent on the presence of inflammatory Ly6C

monocytes/DC.
Neither Ly6C/G
 nor Ly6G
 Cells Affect
Vascular and Stromal Cell Remodeling in the
White Pulp
Remodeling of the white pulp compartment also occurs
during EVL.
6,20 In the white pulp, CD31 is expressed only
on the central arteriole in naïve mice, but with infection it
is expressed also in the neovasculature that emerges
during progressive infection.
6 Strikingly, neither adminis-
tration of Gr-1 or 1A8 mAb had any effect on the neovas-
cularization of the white pulp as measured by CD31

vessels (Figure 2, B, G, and H).
Loss of the FDC and FRC stromal cell networks is also
characteristic of EVL-induced lymphoid tissue remodel-
ing and underpins a loss of T- and B-cell compartmen-
talization.
20 We also assessed, therefore, whether this
process was regulated by either Ly6C/G
 or Ly6G
 cells.
Neither administration of Gr-1 nor 1A8 was able to re-
verse the disruption seen in T- and B-cell compartments
(Figure 3A). Similarly, loss of FRC networks, measured
using gp38 (Figure 3, B, C, and D), and loss of FDC
networks, measured using FDCM1 (Figure 3, B, E, and F),
was equivalent in both Gr-1 and 1A8-treated mice. Thus,
by all criteria measured, white pulp remodeling was in-
dependent of the presence or absence of neutrophils
and monocytes, consistent with the exclusion of these
cells from the white pulp.
Discussion
The present findings provide a number of new insights
into the pathogenesis of EVL-associated splenomegaly.
Figure 3. Neither Ly6C
 inflammatory monocytes/DC nor Ly6G
 neutrophils are responsible for white pulp remodeling. Spleens from L. donovani infected mice
were removed at day 28 after infection and were analyzed, alongside spleens from naïve mice, by IHC. A and B: Spleen sections from naïve mice and infected
mice treated with isotype control, Gr-1, or 1A8 from day 21 to day 28 of infection were stained to identify marginal metallophilic macrophages (CD169; green),
B cells (B220; red), and T cells (CD3; blue) (A) and FRC (gp38, green) and FDC (FDCM1, red) (B). Original magnification, 200. C–F: Computer-assisted
quantitative morphometry was performed to determine the expression of gp38 (C and D) and FDCM1 (E and F) in mice treated with Gr-1 (C and E) and 1A8 (D
and F). Data were generated from multiple sections examined from at least 5 mice per group. *P  0.05, **P  0.01.
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 inflammatory
monocytes/DC located in the red pulp play a major role in
remodeling the red pulp vasculature during ongoing
splenomegaly. The observation that neither neovascular-
istion of the white pulp nor white pulp stromal cell net-
works were affected by monocyte/DC (or neutrophil) de-
pletion suggests strongly that these cells can modify only
their immediate environment.
Our data derived from this model of infection-induced
splenic vascular remodeling are in contrast to a number
of recent reports that implicated neutrophils as major
agents of vascular remodeling: i) neutrophil-derived
MMP-9 was able to direct angiogenesis in collagen on-
plants grafted onto the chorioallantoic membrane of
chick embryos,
21 ii) neutrophil depletion caused a signif-
icant attenuation of microvessel growth in a model of
brain focal angiogenesis induced by AAV-VEGF gene
transfer,
22 and iii) neutrophil depletion reduced the num-
ber of angiogenic islet dysplasias in RIP1-Tag2 mice.
23
However, Gr-1 has often been used as a tool for neutro-
phil depletion in vivo and, as the present findings clearly
indicate, the partial loss of monocytes that occurs as a
result of Gr-1 administration can have profound functional
consequences.
The present findings add to a growing body of evidence
that implicates Ly6C
CD11b
monocytes/DC/myeloid sup-
pressor cells as regulators of vascular growth and remod-
eling. For example, such cells are closely associated with
the vasculature found in spontaneous prostate cancers in
TRAMP mice and produce a range of proangiogenic fac-
tors, including MMP-9.
24 Gr-1
dullCD11b
 cells have been
implicated in ischemia-associated neovascularization, with
adoptive transfer of these cells improving local blood flow in
mice with femoral artery dissection.
25 CD11b
 macro-
phages have also been implicated in inflammation-induced
angiogenesis and lymphangiogenesis in a model of cuta-
neous leishmaniasis, based on in vivo depletion studies
using clodronate liposomes.
16 Even taking into account
variations in phenotypic analysis, differences in methods
of in vivo depletion, and different endpoints for scoring
vascular remodeling, it is difficult to reconcile these data
with a single angiogenic stage of monocyte/macro-
phage/DC differentiation. Rather, it seems likely that the
potential for vascular remodeling exists within mononu-
clear phagocytes at multiple stages of their differentia-
tion, influenced by local environmental factors.
In both macrophages and neutrophils, MMPs (and
MMP-9 in particular) have been implicated as proan-
giogenic factors,
13,21,24 and human monocytes can be
stimulated to produce this metalloproteinase by either
alternative IL-4-mediated activation or IL-10-directed
deactivation.
26 Both cytokines are readily detectable
during EVL.
27 Taken together, these considerations led
us to study the expression of MMP-9 in the spleens of
L. donovani infected mice. Surprisingly, we were un-
able to demonstrate MMP-9 expression in any splenic
mononuclear phagocyte population, whether by flow
cytometry, IHC, or gelatinolytic assays. In neutrophils,
however, MMP-9 was abundant. The absence of de-
tectable levels of MM9 in splenic macrophages of mice
infected with L. donovani would be consistent with the
low levels of alternative activation seen in L. donovani
infection,
28 but may also reflect tissue and/or species-
specific differences in MMP-9 expression by macro-
phages. For example, F4/80
 peritoneal macrophages
expressed significantly more MMP-9 than did neutro-
phils during the early stages of zymosan-induced peri-
tonitis,
29 consistent with a recent report that peritoneal
macrophages infected in vitro with L. chagasi and
cocultured with hepatocytes secrete elevated levels of
active MMP-9.
30 Similarly, whereas in that study resi-
dent peritoneal neutrophils did not express detectable
MMP-9,
29 in the present study neutrophils represent
the only detectable MMP-9
 population in the naïve
spleen. Although the apparently tight regulation of
MMP-9 expression during EVL is of interest, in the
present context it appears that MMP-9 is unlikely to
play a major role in red pulp vascular remodeling.
In summary, we have shown that splenic vascular
remodeling during EVL takes place in a compartment-
specific manner, with red pulp remodeling being reg-
ulated directly or indirectly by Ly6C
 inflammatory
monocytes recruited to this site during infection. Al-
though our findings provide an important mechanistic
insight into the vascularization process that accompa-
nies splenomegaly, the compartment-specific activity
of these monocytes also indicates that some disparate
mechanism or mechanisms must be involved in neo-
vascularization of the white pulp.
6 Further studies are
now required to define the cells and factors involved in
the latter process.
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